SH
SV Health Investors
Venture CapitalActiveSV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
217
Investments
7
Exits
$1.1B
AUM
3.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for SV Health Investors.
Investment Thesis & Strategy
SV Health Investors invests in various stages of biotechnology and healthcare companies, seeking to support innovation and growth within the industry.
Investment Activity
Deals per year over the last 16 years
2
20081
20092
20100
20110
20121
20130
20141
20151
20161
20171
20180
20190
20201
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 217 companies
O
Obsidio Therapeutics
Biotech · Seed, 2023
O
Obsidian Therapeutics
Biotech · Series B, 2021
C
Cerevel Therapeutics
Biotech · Series A, 2018
i
iTeos Therapeutics
Biotech · Series A, 2017
S
Surface Oncology
Biotech · Series A, 2016
V
Voyager Therapeutics
Biotech · Series A, 2015
A
Aura Biosciences
Biotech · Series A, 2013
A
Alnara Pharma
Biotech · Series A, 2010
A
Apellis Pharmaceuticals
Biotech · Series A, 2010
R
Radius Health
Biotech · Series A, 2009
C
Catabasis Pharmaceuticals
Biotech · Series A, 2008
E
Esperion Therapeutics
Biotech · Series A, 2008
Notable Exits
CompanyTypeYearValue / Acquirer
Obsidian TherapeuticsIPO2024—
Achillion PharmaceuticalsAcquisition2019$930M
SequenomAcquisition2016$470M
ReceptosAcquisition2015$7.2B
Portola PharmaceuticalsIPO2013—
AffymaxIPO2007—
PharmacyclicsIPO2004—
Frequently Asked Questions
SV Health Investors focuses on Series A, Series B, Series C+ stage investments.